Categories
Opinion

The elephants in the room – PANDA

While citizens focus on the latest issue the government directs our attention to, many of us have lost sight of the big picture and grown accustomed to severe limitations on our rights like the proverbial frogs in hot water. As a number of countries now seek to focus the discussion on further coercive measures and even mandatory vaccination, PANDA is increasingly aware of the elephants in the room, the topics no one is talking about.

Image source: pandata.org

http://archive.today/2021.09.16-104523/https://www.pandata.org/elephants-in-the-room/

Categories
News

Israel is now the world’s Covid hotspot: Cases soar despite country’s trail-blazing vaccine roll-out – sparking fears other highly-vaccinated countries will be hit by another wave due to jabs’ waning immunity – Daily Mail

Israel has become the Covid capital of the world just months after leading the charge on vaccines, according to data that shows jab protection is waning. Stats compiled by an Oxford University-based research platform show Israel recorded 1,892 cases per million people on Wednesday — nearly 0.2 per cent of the entire population in a single day. That was significantly higher than second worst-hit Mongolia where the rate was 1,119 per million and double the figures for Kosovo (980), Georgia (976) and Montenegro (909), which rounded out the top five

http://archive.today/2021.09.02-232457/https://www.dailymail.co.uk/news/article-9951117/Israel-worlds-Covid-hotspot-0-2-population-catching-yesterday.html

Categories
Publications

Does the FDA think these data justify the first full approval of a covid-19 vaccine? – BMJ

I reiterate our call: “slow down and get the science right—there is no legitimate reason to hurry to grant a license to a coronavirus vaccine.”

FDA should be demanding that the companies complete the two year follow-up, as originally planned (even without a placebo group, much can still be learned about safety). They should demand adequate, controlled studies using patient outcomes in the now substantial population of people who have recovered from covid. And regulators should bolster public trust by helping ensure that everyone can access the underlying data.

http://archive.today/2021.08.24-174356/https://blogs.bmj.com/bmj/2021/08/23/does-the-fda-think-these-data-justify-the-first-full-approval-of-a-covid-19-vaccine/